Global Apheresis Network Management for Cell and Gene Therapies
High-quality starting materials are the cornerstone of successful cell and gene therapy development. Yet the collection and management of those critical materials often receive insufficient focus.
Until something goes wrong.
We brought together an expert panel that collectively manages over 45 collection centers across Europe to share real-world approaches.
The big question? What separates successful starting material programs from those that struggle with variability, delays, and compliance issues?
Meet the Experts
What You'll Learn
🎯 The Standardization Paradox Revealed
Discover why highly standardized GMP manufacturing coexists with completely unstandardized starting material collection, and how successful networks navigate this fundamental contradiction.
🤝 The Barcelona Scaling Model
See how the Barcelona network grew from 6 CAR-T collections to nearly 100 in just two years through centralized coordination, shared resources, and standardized performance management across multiple hospital sites.
📈 Data Bridging: The Future of Network Intelligence
Explore the breakthrough concept of integrating device data, procedure information, and patient biology to shift from reactive problem-solving to predictive quality optimization.
🚀 Practical Network Management Solutions
Understand how to reduce qualification timelines, manage relationships with 20+ manufacturers, and maintain operational consistency across diverse regulatory environments.
Want to discuss your apheresis challenges? Schedule a 15-minute consultation with our network specialists to explore how standardized partnerships could benefit your programs.
